Priveq invests in CSAM’s growth

Priveq Investment Fund IV (”Priveq Investment”) will, through the holding company CSAM Invest AS, inject capital in CSAM Health AS (”CSAM”), a leading provider of software to healthcare providers in Norway and Sweden.The company’s founders and management will together with other employee shareholders maintain a majority ownership in the company, where Priveq’s injection of capital will provide CSAM with further opportunities to continue its successful expansion. 

CSAM is a well-managed and profitable company that has experienced strong and profitable growth. The company offers software to healthcare providers in Norway, Sweden and the UK, with a focus within oncology and maternity treatment areas, as well as providing a platform that enables interaction between healthcare software solutions. The company was founded by the current CEO in 2007 and has exhibited a solid and profitable growth for the last four years, both organically and through acquisitions. For the fiscal year ending 2013, CSAM had sales of around 84 MNOK. CSAM’s head office is located in Oslo, Norway and the company has 70 employees in total.

“CSAM’s strong product offering within its niches combined with a strong customer base, creates a good foundation for continued growth. The company has a dedicated and strong group of employees and an offering that generates added value for both caregivers and patients. We look forward to being an active partner during the company’s exciting journey going forward”, says Louise Nilsson, Partner and Investment manager at Priveq Advisory AB, advisor to Priveq Investment.

“We are very pleased with having Priveq Investment as a new and active partner in CSAM. Priveq, along with its extensive experience from more than 100 growth companies and financial strength, is a perfect partner for CSAM in its continued growth.”, says Ansgar Gabrielsen, Chairman of CSAM Health AS.

Credit Suisse has advised CSAM in the process.

 

For further information, please contact: 

Louise Nilsson, Partner and Investment Manager, Priveq Advisory AB
Mob: +46 709 50 95 50
louise.nilsson@priveq.se

Ansgar Gabrielsen, Chairman, CSAM Health AS
Tel. +47 97 97 27 33
ansgar.gabrielsen@csamhealth.com

Sverre Flatby, CEO, CSAM Health AS
Tel. +47 91 59 91 59
sverre.flatby@csamhealth.com

 

About CSAM Health

CSAM Health AS is based in Norway and provides software solutions which provide caregivers with access to critical and relevant information to assist patients and relatives in the best way possible. CSAM is a leading provider of software within oncology in Scandinavia and pregnancy and childbirth in Norway, with more than 80 installations within 25 hospital groups. In 2013, the company had sales of around 84 MNOK with 70 employees in Norway, Sweden, the UK and the Philippines. Please see 91.225.63.178 for more information.

About Priveq Investment 

Priveq Investment is a private equity company that manages a total of approximately three billion SEK in two funds. The company’s business concept is to create value through long-term investment and active ownership in unlisted growth companies. Investors in Priveq Investment’s funds include Skandia Liv, the Fourth Swedish National Pension Fund (AP4), the Third Swedish National Pension Fund (AP3), Amundi Private Equity Funds, Grosvenor Capital Management, the European Investment Fund (EIF) and Norwegian KLP. Since it was founded in 1983, Priveq Investment has made 112 investments and has participated in the listing of 24 companies. Companies in the current portfolio include Crem International, Duri/Lundbergs, Kung Markatta, Mediplast, Office Management and San Sac. Priveq Advisory AB acts as investment advisor to the Priveq funds. Please see www.priveq.se for more information.

START TYPING AND PRESS ENTER TO SEARCH